US2005020537A1PendingUtilityA1
Bioadhesive antibacterial wound healing composition
Priority: Feb 26, 1999Filed: Aug 25, 2004Published: Jan 27, 2005
Est. expiryFeb 26, 2019(expired)· nominal 20-yr term from priority
A61P 17/00A61L 15/28A61K 45/06A61L 26/0052A61L 15/225A61L 26/0023
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A bioadhesive wound-healing composition includes pullulan, pyruvate, an antioxidant, and a mixture of saturated and unsaturated fatty acids. The composition can be provided in the form of a film that does not self-adhere. The composition can include additional medicinal agents, such as polymyxin B sulfate, bacitracin zinc, and neomycin sulfate. Methods for producing the composition and methods for treating wounds with the composition are also disclosed.
Claims
exact text as granted — not AI-modified1 - 25 . (cancelled)
26 . A bioadhesive film composition wherein said film is a solid film comprising pyruvate, an antioxidant, and a mixture of saturated and unsaturated fatty acids that resuscitate injured mammalian cells.
27 . The composition according to claim 26 , wherein said film comprises an agent selected from the group consisting from pullulan, polyvinyl alcohol, methylcellulose, hydroxymethylcellulose, hydroxypropylmethylcellulose and carboxymethylcellulose and salts thereof and combinations thereof.
28 . The composition according to claim 26 further comprising a anesthetic agent.
29 . The composition according to claim 28 , wherein said anesthetic agent comprises pramoxine hydrochloride.
30 . The composition according to claim 28 , wherein said anesthetic agent comprises lidocaine.
31 . The composition according to claim 28 , wherein said anesthetic agent comprises benzocaine.
32 . The composition according to claim 26 , further comprising an anti-microbial agent.
33 . The composition according to claim 32 , wherein said anti-microbial agent comprises neomycin sulfate.
34 . The composition according to claim 32 , wherein said anti-microbial agent comprises bacitracin zinc.
35 . The composition according to claim 32 , wherein said anti-microbial agent comprises polymyxin B sulfate.
36 . The composition according to claim 32 , wherein said anti-microbial agent comprises triclosan.
37 . The composition according to claim 26 , further comprising a scar reducing agent.
38 . The composition according to claim 37 , wherein said scar reducing agent comprises all forms of vitamin E.
39 . The composition according to claim 26 , further comprising a pharmaceutically active agent.
40 . The composition according to claim 39 , wherein said pharmaceutically active is selected from the groups consisting of immunostimulating agents, antiviral agents antikeratolytic agents, anti-inflammatory agent, antifungal agents, tretinoin, sunscreen agents, dermatological agents, topical antihistamine agents, antibacterial agents, other bioadhesive agents, respiratory bursting inhibitors, inhibitors of prostaglandin synthesis, steroidal anti-inflammatory agents, burn relief medications, sun burn medications, acne preparations, insect bite and sting medications, wound cleansers, wound dressings and combinations thereof.
41 . The composition according to claim 26 , wherein said film is a standalone film.
42 . The composition according to claim 26 , wherein said film is a solid dried film.
43 . The composition according to claim 26 , wherein said film is a single layer film.Join the waitlist — get patent alerts
Track US2005020537A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.